Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fierce Health vs HealthOn

Fierce Health
Graded #411

Lower grade

vs+2.5
HealthOn
Graded #349

Higher grade

The verdict

HealthOn takes it — 59.1/100 to 56.6/100.

HealthOn grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HealthOn offers compounded semaglutide and tirzepatide starting at $155/month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHealthOn +13
33
46
Dose & formulationFierce Health +13
77
64
Clinical oversightHealthOn +17
62
79
Labs & monitoringEven
52
52
FulfillmentFierce Health +13
75
62
Contract termsEven
47
47
Fierce Health · left barHealthOn · right bar

The numbers

MetricFierce HealthHealthOn
WeighScore56.6/10059.1/100
GradeCC
Scorecard rank#411#349
Semaglutide$297/mo (3-month plan, compounded)$189/mo (starting dose, 12-month plan, compounded)
Tirzepatide$497/mo (3-month plan, compounded)$290/mo (starting dose, 12-month plan, compounded)
Coverage30 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Fierce Health

Graded #411 · C

Strengths

  • 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer on every product page
  • Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
  • Microdose tier at $197/mo is one of the lower entry points we've seen

Where it loses points

  • No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
  • Operating LLC name not disclosed anywhere on the site
  • Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
  • Clinical provider network not named
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
HealthOn

Graded #349 · C

Strengths

  • Both compounded semaglutide and tirzepatide available
  • Weight-loss pricing starts at $189/mo for compounded semaglutide

Where it loses points

  • No visible LegitScript certification or PCAB accreditation
  • State availability not publicly disclosed
  • Lowest advertised prices require a 12-month plan commitment

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard